Primary Immunodeficiency Disease Clinical Trials Primary Immunodeficiency Disease RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Allogeneic Hematopoietic Stem Cell Transplant for People With Primary Immunodeficiency Diseases
Conditions:   Lymphoproliferative Disorders;   Autoimmune Lymphoproliferative;   Immune System Diseases;   Common Variable Immunodeficiency;   Primary T-cell Immunodeficiency Disorders Interventions:   Drug: Busulfan test dose;   Drug: Fludarabine;   Drug: Busulfan;   Drug: Alemtuzumab;   Radiation: Total body Irradiation;   Procedure: Allogeneic HSCT;   Drug: Tacrolimus (Tacro);   Drug: Mycophenolate mofetil (MMF);   Drug: Cyclophosphamide (Cytoxan);   Other: No i ntervention Sponsor:   National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 9, 2020 Category: Research Source Type: clinical trials

Study to Evaluate the Efficacy, Tolerability and Safety of Subcutaneous Human Immunoglobulin (Octanorm) in Patients With Primary Immunodeficiency Diseases
Condition:   Primary Immune Deficiency Disorder Intervention:   Biological: Octanorm Sponsor:   Octapharma Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 17, 2019 Category: Research Source Type: clinical trials